View in EDS

Oral cavity cancer after sublingual buprenorphine use.

Saved in:
Bibliographic Details
Title: Oral cavity cancer after sublingual buprenorphine use.
Authors: Abruzzo AR; Harvard Medical School, Boston, MA, USA; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA., Harris MTH; Grayken Center for Addiction, Section of General Internal Medicine, Clinical Addiction Research and Education Unit, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA., Sroussi HY; Division of Oral Medicine and Dentistry, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Oral Medicine and Oral Oncology Treatment Center, Dana-Farber Cancer Institute, Boston, MA, USA., Suzuki J; Division of Addiction Psychiatry, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA., Kass JI; Reliant Medical Group, Worcester, MA, USA., Rettig EM; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA; Head and Neck Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: emrettig@bwh.harvard.edu.
Source: Oral oncology [Oral Oncol] 2025 Sep; Vol. 168, pp. 107573. Date of Electronic Publication: 2025 Aug 05.
Publication Type: Case Reports; Letter
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40769054
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Oral cavity cancer after sublingual buprenorphine use.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Abruzzo+AR%22">Abruzzo AR</searchLink>; Harvard Medical School, Boston, MA, USA; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Harris+MTH%22">Harris MTH</searchLink>; Grayken Center for Addiction, Section of General Internal Medicine, Clinical Addiction Research and Education Unit, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sroussi+HY%22">Sroussi HY</searchLink>; Division of Oral Medicine and Dentistry, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Oral Medicine and Oral Oncology Treatment Center, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Suzuki+J%22">Suzuki J</searchLink>; Division of Addiction Psychiatry, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kass+JI%22">Kass JI</searchLink>; Reliant Medical Group, Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rettig+EM%22">Rettig EM</searchLink>; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA; Head and Neck Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: emrettig@bwh.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229709118%22">Oral oncology</searchLink> [Oral Oncol] 2025 Sep; Vol. 168, pp. 107573. <i>Date of Electronic Publication: </i>2025 Aug 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9709118 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0593 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213688375%22">13688375 </searchLink><i>NLM ISO Abbreviation: </i>Oral Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40769054
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.oraloncology.2025.107573
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 107573
    Titles:
      – TitleFull: Oral cavity cancer after sublingual buprenorphine use.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abruzzo AR
      – PersonEntity:
          Name:
            NameFull: Harris MTH
      – PersonEntity:
          Name:
            NameFull: Sroussi HY
      – PersonEntity:
          Name:
            NameFull: Suzuki J
      – PersonEntity:
          Name:
            NameFull: Kass JI
      – PersonEntity:
          Name:
            NameFull: Rettig EM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0593
          Numbering:
            – Type: volume
              Value: 168
          Titles:
            – TitleFull: Oral oncology
              Type: main
ResultId 1